The cluster of open-market sales by the entire C-suite and key officers, without 10b5-1 plan designations, is a bearish signal. Watch for any upcoming clinical data readouts or regulatory updates that could have prompted this coordinated profit-taking. The pattern of exercise-and-sell suggests insiders are monetizing options at current elevated levels.
Price Chart
Executive Summary
Six Pharvaris insiders, including the CEO, President, and CCO, sold a total of ~$4.13M in open-market shares over a one-week window. The sales are concentrated among top executives and follow recent option exercises, suggesting profit-taking after the stock's run-up rather than a single informed negative catalyst. The cluster is notable in dollar terms but represents a modest fraction of market cap, and the sales are largely consistent with post-vesting liquidity diversification.
Key Financial Metrics
Key Facts
- Total open-market sales of ~$4.13M by 6 insiders over 7 days
- CEO Modig Berndt sold 2,291 shares for ~$90K
- President Lu Peng sold 15,000 shares for ~$602K
- Chief Commercial Officer Souverijns Wim sold 26,090 shares for ~$1.02M
- Chief Early Development Lesage Anne sold 30,000 shares for ~$1.15M
- Chief Technical Ops Officer Abele Stefan Andreas sold 45,000 shares for ~$1.72M
- Multiple insiders exercised options at low strike prices ($0-$22) before selling at ~$38-40
- No 10b5-1 plan indication for any of the open-market sales
Financial Impact
Total insider sales of ~$4.13M represent approximately 1.3% of the company's ~$326M market cap
Risk Factors
- Insiders may be selling ahead of negative clinical or regulatory news
- Continued insider selling could pressure the stock and signal lack of confidence in near-term catalysts
- The stock's recent run-up may have created a selling opportunity that insiders are exploiting
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1790017892681 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | Insider Cluster | $32.02 $31.19 | ▲ +2.59% | ▲ +2.37% | $31.95 (+0.22%) |
Sep 24, 2026 4w ago | Insider Cluster | $32.99 $31.01 | ▲ +6.00% | ▲ +5.59% | $31.95 (+3.15%) |
Sep 24, 2026 4w ago | Insider Cluster | $32.99 $31.01 | ▲ +6.00% | ▲ +5.59% | $31.95 (+3.15%) |
Sep 23, 2026 4w ago | Insider Cluster | $33.07 $31.72 | ▲ +4.08% | ▲ +3.41% | $31.95 (+3.39%) |
Sep 21, 2026 5w ago | Insider Cluster | $36.02 $31.91 | ▲ +11.41% | ▲ +10.39% | $31.95 (+11.30%) |
Sep 17, 2026 5w ago | 144 | $36.37 $32.02 | ▲ +11.96% | ▲ +13.23% | $31.95 (+12.15%) |
Sep 17, 2026 5w ago | Insider Cluster | $38.00 $32.99 | ▲ +13.18% | ▲ +13.78% | $31.95 (+15.92%) |
Sep 17, 2026 5w ago | Insider Cluster | $38.00 $32.99 | ▲ +13.18% | ▲ +13.78% | $31.95 (+15.92%) |
Sep 16, 2026 5w ago | Insider Cluster | $37.55 $33.07 | ▲ +11.93% | ▲ +13.76% | $31.95 (+14.91%) |
Sep 15, 2026 6w ago | Insider Cluster | $38.06 $36.37 | ▲ +4.44% | ▲ +5.26% | $31.95 (+16.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers